Low-dose Growth Hormone for the Treatment of Gastroparesis
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Symptoms \> 6 months that have not responded satisfactorily to standard treatment.
• For gastroparesis: Gastroparesis Cardinal Symptom Index (GCSI) score of \>21
Locations
United States
Arizona
Mayo Clinic
RECRUITING
Phoenix
Mayo Clinic in Arizona
RECRUITING
Scottsdale
Contact Information
Primary
Guillermo GI Program Coordinator, Research
barahona.guillermo@mayo.edu
480-301-4679
Backup
Tisha Lunsford, MD
lunsford.tisha@mayo.edu
Time Frame
Start Date: 2024-10-22
Estimated Completion Date: 2027-12
Participants
Target number of participants: 10
Treatments
Experimental: Treatment Group
Patients with Gastroparesis
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic